{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:35:56Z","timestamp":1787664956025,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["Postdoctoral fellowship award"],"award-info":[{"award-number":["Postdoctoral fellowship award"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Council of Thailand and Mahidol University","award":["N42A650372"],"award-info":[{"award-number":["N42A650372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27512-w","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:13:46Z","timestamp":1765538026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification and functional characterization of splicing factors implicated in mantle cell lymphoma aggressiveness"],"prefix":"10.1038","volume":"15","author":[{"given":"Juthamas","family":"Yosudjai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirarat","family":"Poohadsuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinya","family":"Samart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napachai","family":"Rodboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudjit","family":"Luanpitpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"27512_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","volume":"34","author":"A Navarro","year":"2020","unstructured":"Navarro, A., Be\u00e0, S., Jares, P. & Campo, E. Molecular pathogenesis of mantle cell lymphoma. Hematol Oncol Clin North Am. 34, 795\u2013807 (2020).","journal-title":"Hematol Oncol Clin North Am."},{"key":"27512_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cells 100, 57\u201370 (2000).","journal-title":"Cells"},{"key":"27512_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1182\/blood.2019004260","volume":"138","author":"S Chen","year":"2021","unstructured":"Chen, S., Benbarche, S. & Abdel-Wahab, O. Splicing factor mutations in hematologic malignancies. Blood 138, 599\u2013612 (2021).","journal-title":"Blood"},{"key":"27512_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood.2019002385","volume":"136","author":"P Pararajalingam","year":"2020","unstructured":"Pararajalingam, P. et al. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood 136, 572\u2013584 (2020).","journal-title":"Blood"},{"key":"27512_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3892\/br.2014.407","volume":"3","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Mechanism of alternative splicing and its regulation. Biomed Rep. 3, 152\u2013158 (2014).","journal-title":"Biomed Rep."},{"key":"27512_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2777","volume":"10","author":"M Chen","year":"2009","unstructured":"Chen, M. & Manley, J. L. Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches. Nat Rev Mol Cell Biol. 10, 741\u2013754 (2009).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"27512_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470\u2013476 (2008).","journal-title":"Nature"},{"key":"27512_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fcell.2020.00474","volume":"8","author":"A Cerasuolo","year":"2020","unstructured":"Cerasuolo, A., Buonaguro, L., Buonaguro, F. M. & Tornesello, M. L. The role of RNA splicing factors in cancer: Regulation of viral and human gene expression in human papillomavirus-related cervical cancer. Front Cell Dev Biol. 8, 474 (2020).","journal-title":"Front Cell Dev Biol."},{"key":"27512_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","volume":"9","author":"Y Tao","year":"2024","unstructured":"Tao, Y., Zhang, Q., Wang, H., Yang, X. & Mu, H. Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Ther. 9, 26 (2024).","journal-title":"Signal Transduct Target Ther."},{"key":"27512_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41419-022-05470-9","volume":"14","author":"OM Ivanova","year":"2023","unstructured":"Ivanova, O. M. et al. Non-canonical functions of spliceosome components in cancer progression. Cell Death Dis. 14, 77 (2023).","journal-title":"Cell Death Dis."},{"key":"27512_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41408-018-0114-3","volume":"8","author":"H Quentmeier","year":"2018","unstructured":"Quentmeier, H. et al. RBFOX2 and alternative splicing in B-cell lymphoma. Blood Cancer J. 8, 77 (2018).","journal-title":"Blood Cancer J."},{"key":"27512_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41467-020-20848-z","volume":"12","author":"VV Grinev","year":"2021","unstructured":"Grinev, V. V. et al. RUNX1\/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia. Nat Commun. 12, 520 (2021).","journal-title":"Nat Commun."},{"key":"27512_CR13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41467-020-15733-8","volume":"11","author":"SS Itskovich","year":"2020","unstructured":"Itskovich, S. S. et al. MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia. Nat Commun. 11, 2369 (2020).","journal-title":"Nat Commun."},{"key":"27512_CR14","doi-asserted-by":"publisher","first-page":"9998927","DOI":"10.1155\/2023\/9998927","volume":"2023","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Increased expression of SRSF1 predicts poor prognosis in multiple myeloma. J Oncol. 2023, 9998927 (2023).","journal-title":"J Oncol."},{"key":"27512_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-022-02124-7","volume":"128","author":"S Song","year":"2023","unstructured":"Song, S. et al. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis. Br J Cancer. 128, 1086\u20131094 (2023).","journal-title":"Br J Cancer."},{"key":"27512_CR16","doi-asserted-by":"publisher","first-page":"4013658","DOI":"10.1155\/2020\/4013658","volume":"2020","author":"H Bai","year":"2020","unstructured":"Bai, H. & Chen, B. Abnormal PTBP1 expression sustains the disease progression of multiple myeloma. Dis Markers. 2020, 4013658 (2020).","journal-title":"Dis Markers."},{"key":"27512_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14348\/molcells.2017.2319","volume":"40","author":"S Jeong","year":"2017","unstructured":"Jeong, S. SR Proteins: binders, regulators, and connectors of RNA. Mol. Cells 40, 1\u20139 (2017).","journal-title":"Mol. Cells"},{"key":"27512_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: Insights into their role in health and disease. Hum Genet. 135, 851\u2013867 (2016).","journal-title":"Hum Genet."},{"key":"27512_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ng1532","volume":"37","author":"K Basso","year":"2005","unstructured":"Basso, K. et al. Reverse engineering of regulatory networks in human B cells. Nat Genet. 37, 382\u2013390 (2005).","journal-title":"Nat Genet."},{"key":"27512_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","volume":"12","author":"S Das","year":"2014","unstructured":"Das, S. & Krainer, A. R. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res. 12, 1195\u20131204 (2014).","journal-title":"Mol Cancer Res."},{"key":"27512_CR21","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/app12052268","volume":"12","author":"A Lo Giudice","year":"2022","unstructured":"Lo Giudice, A. et al. The clinical role of SRSF1 expression in cancer: A review of the current literature. Appl Sci. 12, 2268 (2022).","journal-title":"Appl Sci."},{"issue":"Suppl","key":"27512_CR22","first-page":"S129","volume":"9","author":"N Han","year":"2013","unstructured":"Han, N., Li, W. & Zhang, M. The function of the RNA-binding protein hnRNP in cancer metastasis. J Cancer Res Ther. 9(Suppl), S129\u2013S134 (2013).","journal-title":"J Cancer Res Ther."},{"key":"27512_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1631\/jzus.B1900422","volume":"21","author":"W Zhu","year":"2020","unstructured":"Zhu, W. et al. Roles of PTBP1 in alternative splicing, glycolysis, and oncogenesis. J Zhejiang Univ Sci B. 21, 122\u2013136 (2020).","journal-title":"J Zhejiang Univ Sci B."},{"key":"27512_CR24","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1016\/j.bbadis.2018.09.010","volume":"1864","author":"S Luanpitpong","year":"2018","unstructured":"Luanpitpong, S. et al. Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma. Biochim Biophys Acta Mol Basis Dis. 1864, 3739\u20133753 (2018).","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"27512_CR25","doi-asserted-by":"publisher","first-page":"14350","DOI":"10.18632\/oncotarget.7320","volume":"7","author":"H Zhang","year":"2016","unstructured":"Zhang, H., Chen, Z., Neelapu, S. S., Romaguera, J. & McCarty, N. Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment. Oncotarget 7, 14350\u201314365 (2016).","journal-title":"Oncotarget"},{"key":"27512_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/1078-0432.CCR-15-0987","volume":"22","author":"Z Chen","year":"2015","unstructured":"Chen, Z., Teo, A. E. & McCarty, N. ROS-induced CXCR4 signaling regulates mantle cell lymphoma (MCL) cell survival and drug resistance in the bone marrow microenvironment via autophagy. Clin Cancer Res. 22, 187\u2013199 (2015).","journal-title":"Clin Cancer Res."},{"key":"27512_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07231.x","volume":"154","author":"K Wolf","year":"2006","unstructured":"Wolf, K. & Friedl, P. Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol. 154, 11\u201315 (2006).","journal-title":"Br J Dermatol."},{"key":"27512_CR28","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","volume":"124","author":"J Palomero","year":"2014","unstructured":"Palomero, J. et al. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood 124, 2235\u20132247 (2014).","journal-title":"Blood"},{"key":"27512_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30, 87 (2011).","journal-title":"J Exp Clin Cancer Res."},{"key":"27512_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/annonc\/mdn656","volume":"20","author":"A Goy","year":"2009","unstructured":"Goy, A. et al. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Ann Oncol. 20, 520\u2013525 (2009).","journal-title":"Ann Oncol."},{"key":"27512_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2141.2008.07466.x","volume":"145","author":"OA O\u2019Connor","year":"2009","unstructured":"O\u2019Connor, O. A. et al. Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial. Br J Haematol. 145, 34\u201339 (2009).","journal-title":"Br J Haematol."},{"key":"27512_CR32","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.3390\/ijms21238974","volume":"21","author":"T Ichimiya","year":"2020","unstructured":"Ichimiya, T. et al. Autophagy and autophagy-related diseases: A review. Int J Mol Sci. 21, 8974 (2020).","journal-title":"Int J Mol Sci."},{"key":"27512_CR33","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.3390\/cancers13225622","volume":"13","author":"S Patergnani","year":"2021","unstructured":"Patergnani, S. et al. Understanding the role of autophagy in cancer formation and progression is a real opportunity to treat and cure human cancers. Cancers (Basel). 13, 5622 (2021).","journal-title":"Cancers (Basel)."},{"key":"27512_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/cdd.2008.168","volume":"16","author":"CM Fader","year":"2008","unstructured":"Fader, C. M. & Colombo, M. I. Autophagy and multivesicular bodies: Two closely related partners. Cell Death Differ. 16, 70\u201378 (2008).","journal-title":"Cell Death Differ."},{"key":"27512_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/EBC20170035","volume":"61","author":"T Lamark","year":"2017","unstructured":"Lamark, T., Svenning, S. & Johansen, T. Regulation of selective autophagy: The p62\/SQSTM1 paradigm. Essays Biochem. 61, 609\u2013664 (2017).","journal-title":"Essays Biochem."},{"key":"27512_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/15548627.2015.1017181","volume":"11","author":"S Guo","year":"2015","unstructured":"Guo, S. et al. A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy 11, 560\u2013572 (2015).","journal-title":"Autophagy"},{"key":"27512_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrm.2017.27","volume":"18","author":"FE Baralle","year":"2017","unstructured":"Baralle, F. E. & Giudice, J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 18, 437\u2013451 (2017).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"27512_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-021-00495-6","volume":"6","author":"Y Lv","year":"2021","unstructured":"Lv, Y. et al. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduct. Target Ther. 6, 108 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"27512_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/1541-7786.MCR-11-0061","volume":"9","author":"JC Shultz","year":"2011","unstructured":"Shultz, J. C. et al. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non\u2013small cell lung cancer cells. Mol Cancer Res. 9, 889\u2013900 (2011).","journal-title":"Mol Cancer Res."},{"key":"27512_CR40","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1093\/nar\/gku922","volume":"42","author":"P Bielli","year":"2014","unstructured":"Bielli, P., Bordi, M., Biasio, V. D. & Sette, C. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1\/hnRNP I) in alternative 5\u2032 splice site selection. Nucleic Acids Res. 42, 12070\u201312081 (2014).","journal-title":"Nucleic Acids Res."},{"key":"27512_CR41","doi-asserted-by":"publisher","first-page":"22641","DOI":"10.1074\/jbc.M501070200","volume":"280","author":"D Garneau","year":"2005","unstructured":"Garneau, D., Revil, T., Fisette, J. F. & Chabot, B. Heterogeneous nuclear ribonucleoprotein F\/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem. 280, 22641\u201322650 (2005).","journal-title":"J Biol Chem."},{"key":"27512_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrg3778","volume":"15","author":"XD Fu","year":"2014","unstructured":"Fu, X. D. & Ares, M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet. 15, 689\u2013701 (2014).","journal-title":"Nat Rev Genet."},{"key":"27512_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molcel.2013.03.001","volume":"50","author":"S Pandit","year":"2013","unstructured":"Pandit, S. et al. Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol Cell. 50, 223\u2013235 (2013).","journal-title":"Mol Cell."},{"key":"27512_CR44","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.neuron.2006.11.005","volume":"52","author":"S Sharma","year":"2006","unstructured":"Sharma, S. & Black, D. L. Maps, codes, and sequence elements: Can we predict the protein output from an alternatively spliced locus?. Neuron 52, 574\u2013576 (2006).","journal-title":"Neuron"},{"key":"27512_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10428194.2019.1675877","volume":"61","author":"D Filip","year":"2019","unstructured":"Filip, D. & Mr\u00e1z, M. The role of MYC in the transformation and aggressiveness of \u201cindolent\u201d B-cell malignancies. Leuk Lymphoma. 61, 510\u2013524 (2019).","journal-title":"Leuk Lymphoma."},{"key":"27512_CR46","first-page":"1171","volume":"109","author":"JM Rodrigues","year":"2024","unstructured":"Rodrigues, J. M. et al. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53\/p53\u2013a Nordic Lymphoma Group study. Haematologica 109, 1171 (2024).","journal-title":"Haematologica"},{"key":"27512_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"27512_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-cancerbio-030617-050407","volume":"3","author":"L Escobar-Hoyos","year":"2019","unstructured":"Escobar-Hoyos, L., Knorr, K. & Abdel-Wahab, O. Aberrant RNA splicing in cancer. Annu Rev Cancer Biol. 3, 167\u2013185 (2019).","journal-title":"Annu Rev Cancer Biol."},{"key":"27512_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczuk\u00f3w, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer. 23, 135\u2013155 (2023).","journal-title":"Nat. Rev. Cancer."},{"key":"27512_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2020.10.008","volume":"57","author":"S Paz","year":"2021","unstructured":"Paz, S., Ritchie, A., Mauer, C. & Caputi, M. The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system. Cytokine Growth Factor Rev. 57, 19\u201326 (2021).","journal-title":"Cytokine Growth Factor Rev."},{"key":"27512_CR51","doi-asserted-by":"publisher","first-page":"e02028","DOI":"10.7554\/eLife.02028","volume":"3","author":"MM Maslon","year":"2014","unstructured":"Maslon, M. M., Heras, S. R., Bellora, N., Eyras, E. & C\u00e1ceres, J. F. The translational landscape of the splicing factor SRSF1 and its role in mitosis. Elife 3, e02028 (2014).","journal-title":"Elife"},{"key":"27512_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molcel.2015.09.005","volume":"60","author":"O Anczuk\u00f3w","year":"2015","unstructured":"Anczuk\u00f3w, O. et al. SRSF1-regulated alternative splicing in breast cancer. Mol Cell. 60, 105\u2013117 (2015).","journal-title":"Mol Cell."},{"key":"27512_CR53","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/s41467-022-30489-z","volume":"13","author":"AE Hall","year":"2022","unstructured":"Hall, A. E. et al. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer. Nat Commun. 13, 2791 (2022).","journal-title":"Nat Commun."},{"key":"27512_CR54","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s41374-018-0128-2","volume":"98","author":"E Mart\u00ednez-Terroba","year":"2018","unstructured":"Mart\u00ednez-Terroba, E. et al. The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer. Lab Investig. 98, 1562\u20131574 (2018).","journal-title":"Lab Investig."},{"key":"27512_CR55","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1038\/s41598-021-84403-6","volume":"11","author":"ZH Wu","year":"2021","unstructured":"Wu, Z. H., Tang, Y. & Zhou, Y. Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer. Sci Rep. 11, 4841 (2021).","journal-title":"Sci Rep."},{"key":"27512_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12964-020-00615-9","volume":"18","author":"YF Xu","year":"2020","unstructured":"Xu, Y. F. et al. SRSF1 regulates exosome microRNA enrichment in human cancer cells. Cell Commun Signal. 18, 130 (2020).","journal-title":"Cell Commun Signal."},{"key":"27512_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051497","volume":"7","author":"HL Gautrey","year":"2012","unstructured":"Gautrey, H. L. & Tyson-Capper, A. J. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells. PLoS ONE 7, e51497 (2012).","journal-title":"PLoS ONE"},{"key":"27512_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41408-022-00759-6","volume":"12","author":"A Aktas Samur","year":"2022","unstructured":"Aktas Samur, A. et al. In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood Cancer J. 12, 171 (2022).","journal-title":"Blood Cancer J."},{"key":"27512_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2017.03.013","volume":"396","author":"H K\u0119dzierska","year":"2017","unstructured":"K\u0119dzierska, H. & Piekie\u0142ko-Witkowska, A. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer. Cancer Lett. 396, 53\u201365 (2017).","journal-title":"Cancer Lett."},{"key":"27512_CR60","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1101\/gad.305862.117","volume":"31","author":"H Huang","year":"2017","unstructured":"Huang, H., Zhang, J., Harvey, S. E., Hu, X. & Cheng, C. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF. Genes Dev. 31, 2296\u20132309 (2017).","journal-title":"Genes Dev."},{"key":"27512_CR61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220190120","volume":"120","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells. Proc Natl Acad Sci USA. 120, e2220190120 (2023).","journal-title":"Proc Natl Acad Sci USA."},{"key":"27512_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ebiom.2019.06.017","volume":"45","author":"F Li","year":"2019","unstructured":"Li, F. et al. HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3\u2032 UTR. EBioMedicine 45, 208\u2013219 (2019).","journal-title":"EBioMedicine"},{"key":"27512_CR63","first-page":"7035","volume":"11","author":"F Li","year":"2019","unstructured":"Li, F. et al. HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer. Am J Transl Res. 11, 7035 (2019).","journal-title":"Am J Transl Res."},{"key":"27512_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/jca.50490","volume":"12","author":"F Li","year":"2021","unstructured":"Li, F. et al. HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K\/AKT\/FOXO1. J Cancer. 12, 281 (2021).","journal-title":"J Cancer."},{"key":"27512_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032428","volume":"101","author":"Q Huang","year":"2022","unstructured":"Huang, Q., Gu, S., Fang, J., Li, X. & Lin, L. A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors. Medicine 101, e32428 (2022).","journal-title":"Medicine"},{"key":"27512_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17387","volume":"9","author":"Z He","year":"2023","unstructured":"He, Z. et al. PTBP1 promotes hepatocellular carcinoma progression by regulating the skipping of exon 9 in NUMB pre-mRNA. Heliyon. 9, e17387 (2023).","journal-title":"Heliyon."},{"key":"27512_CR67","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang, Z. J., Chee, C. E., Huang, S. & Sinicrope, F. A. The role of autophagy in cancer: Therapeutic implications. Mol Cancer Ther. 10, 1533\u20131541 (2011).","journal-title":"Mol Cancer Ther."},{"key":"27512_CR68","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3324\/haematol.2012.079061","volume":"98","author":"A Nencioni","year":"2013","unstructured":"Nencioni, A. et al. Autophagy in blood cancers: Biological role and therapeutic implications. Haematologica 98, 1335\u20131343 (2013).","journal-title":"Haematologica"},{"key":"27512_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biology8040082","volume":"8","author":"B Linder","year":"2019","unstructured":"Linder, B. & K\u00f6gel, D. Autophagy in cancer cell death. Biology. 8, 82 (2019).","journal-title":"Biology."},{"key":"27512_CR70","first-page":"902","volume":"26","author":"GE Jiao","year":"2013","unstructured":"Jiao, G. E. et al. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt\/mTOR and activating p38-MAPK. Biomed Environ Sci. 26, 902\u2013911 (2013).","journal-title":"Biomed Environ Sci."},{"key":"27512_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029014","volume":"6","author":"HL Huang","year":"2011","unstructured":"Huang, H. L. et al. Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells. PLoS ONE 6, e29014 (2011).","journal-title":"PLoS ONE"},{"key":"27512_CR72","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3892\/or.2014.3369","volume":"32","author":"CL Li","year":"2014","unstructured":"Li, C. L. et al. Arsenic trioxide induces autophagy and antitumor effects in Burkitt\u2019s lymphoma Raji cells. Oncol Rep. 32, 1557\u20131563 (2014).","journal-title":"Oncol Rep."},{"issue":"22","key":"27512_CR73","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1101\/gad.305862.117","volume":"31","author":"H Huang","year":"2017","unstructured":"Huang, H., Zhang, J., Harvey, S. E., Hu, X. & Cheng, C. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF. Genes Dev. 31(22), 2296\u20132309 (2017).","journal-title":"Genes Dev."},{"issue":"5","key":"27512_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1788","volume":"14","author":"T Brownmiller","year":"2023","unstructured":"Brownmiller, T. & Caplen, N. J. The HNRNPF\/H RNA binding proteins and disease. Wiley Interdiscip Rev RNA. 14(5), e1788 (2023).","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"27512_CR75","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fgene.2019.00804","volume":"10","author":"M Stevens","year":"2019","unstructured":"Stevens, M. & Oltean, S. Modulation of the apoptosis gene Bcl-x function through alternative splicing. Front Genet. 10, 804 (2019).","journal-title":"Front Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27512-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27512-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27512-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:02:41Z","timestamp":1765540961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27512-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27512"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27512-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All cell lines used in this study were purchased from ATCC, Thermo Fisher Scientific, and JCRB Cell Bank.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"43709"}}